- Filed
- Apr 23, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 23, 2026 | 8.91M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.9M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 0 sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$166.39K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$34.69K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $590.2K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$1.83M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.72M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$23.81K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $10.88K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $75K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $75K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.49M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.49M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $656.95K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $765.59K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $72.13M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $71.62M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.08 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $108.64K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $34.69K |
| Net Income | Q1 2026 · Mar 31, 2026 | $509.85K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$34.69K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$108.64K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$34.69K |